Insider · CIK 0001233684

COOK DAVID N

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001233684

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-02-28	Forma Therapeutics Holdings, Inc.A Award	SVP, Chief Scientific Officer	AAward	+25K sh	—	—	41,469
2022-02-28	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	SVP, Chief Scientific Officer	AAward	+37.5K sh	—	—	37,500
2022-02-23	Forma Therapeutics Holdings, Inc.S Sale	SVP, Chief Scientific Officer	SSale	−3,531 sh	$9.78	−$34.5K	16,469
2021-02-26	Forma Therapeutics Holdings, Inc.A Award	SVP, Chief Scientific Officer	AAward	+14.3K sh	—	—	14,300
2021-02-26	Forma Therapeutics Holdings, Inc.A Award	SVP, Chief Scientific Officer	AAward	+5,700 sh	—	—	20,000
2021-02-26	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	SVP, Chief Scientific Officer	AAward	+43.6K sh	—	—	43,550
2020-06-18	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	SVP, Chief Scientific Officer	AAward	+23.4K sh	—	—	0
2019-01-26	MCRBSeres Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+7,500 sh	—	—	147,435
2019-01-26	MCRBSeres Therapeutics, Inc. · RESTRICTED STOCK UNITSM Exercise/Conversion	See Remarks	MExercise/Conversion	−7,500 sh	—	—	12,500
2018-01-30	MCRBSeres Therapeutics, Inc. · STOCK OPTION (RIGHT TO BUY)A Award	See Remarks	AAward	−75K sh	—	—	75,000
2018-01-26	MCRBSeres Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+5,000 sh	—	—	141,673
2018-01-26	MCRBSeres Therapeutics, Inc.S Sale	See Remarks	SSale	−1,738 sh	$11.02	−$19.2K	139,935
2018-01-26	MCRBSeres Therapeutics, Inc. · RESTRICTED STOCK UNITSM Exercise/Conversion	See Remarks	MExercise/Conversion	−5,000 sh	—	—	20,000
2017-01-26	MCRBSeres Therapeutics, Inc. · Stock Option (right to buy)A Award	See Remarks	AAward	+75K sh	—	—	75,000
2017-01-26	MCRBSeres Therapeutics, Inc. · Restricted Stock UnitsA Award	See Remarks	AAward	+25K sh	—	—	25,000
2016-06-02	MCRBSeres Therapeutics, Inc.S Sale	See Remarks	SSale	−8,000 sh	$31.00	−$248K	136,673
2016-06-01	MCRBSeres Therapeutics, Inc.S Sale	See Remarks	SSale	−16K sh	$29.43	−$471K	144,673
2016-04-07	MCRBSeres Therapeutics, Inc.S Sale	See Remarks	SSale	−8,000 sh	$31.00	−$248K	160,673
2016-04-04	MCRBSeres Therapeutics, Inc.S Sale	See Remarks	SSale	−8,000 sh	$28.00	−$224K	168,673
2016-04-01	MCRBSeres Therapeutics, Inc.S Sale	See Remarks	SSale	−46.7K sh	$25.74	−$1.2M	183,023
2016-04-01	MCRBSeres Therapeutics, Inc.S Sale	See Remarks	SSale	−6,350 sh	$26.90	−$171K	176,673
2016-02-01	MCRBSeres Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+87.5K sh	—	—	87,500
2015-06-26	MCRBSeres Therapeutics, Inc.C Conversion	See Remarks	CConversion	+45.5K sh	—	—	229,673
2015-06-26	MCRBSeres Therapeutics, Inc. · Series B Convertible Preferred StockC Conversion	See Remarks	CConversion	−45.5K sh	—	—	0
2015-06-25	MCRBSeres Therapeutics, Inc. · Stock Option (right to buy)A Award	See Remarks	AAward	+90K sh	—	—	90,000
2007-10-01	CERSCERUS CORP · Option (Right to Buy)A Award	Vice President, R & D	AAward	+30K sh	—	—	30,000
2006-10-02	CERSCERUS CORP · Option (Right to Buy)A Award	Vice President, R & D	AAward	+30K sh	—	—	30,000
2006-01-09	CERSCERUS CORPA Award	Vice President, R & D	AAward	+4,033 sh	—	—	37,866
2005-10-03	CERSCERUS CORP · Option (Right to Buy)A Award	Vice President, R & D	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Mar 24
COOK DAVID N0000899243-22-008644
SEC(opens sec.gov)
Feb 254
COOK DAVID N0000899243-22-007924
SEC(opens sec.gov)
Mar 24
COOK DAVID N0000899243-21-009155
SEC(opens sec.gov)
Jun 224
COOK DAVID N0000899243-20-017449
SEC(opens sec.gov)
Jan 294
COOK DAVID N0000899243-19-002136
SEC(opens sec.gov)
Jan 304
COOK DAVID N0000899243-18-002327
SEC(opens sec.gov)
Jan 274
Seres Therapeutics, Inc.0000899243-17-002119
SEC(opens sec.gov)
Jun 64
Seres Therapeutics, Inc.0000899243-16-021793
SEC(opens sec.gov)
Jun 24
Seres Therapeutics, Inc.0000899243-16-021564
SEC(opens sec.gov)
Apr 114
Seres Therapeutics, Inc.0000899243-16-017929
SEC(opens sec.gov)
Apr 54
Seres Therapeutics, Inc.0000899243-16-017712
SEC(opens sec.gov)

Companies

Address

C/O SERES THERAPEUTICS, INC. 215 FIRST STREET

CAMBRIDGE, MA, 02142